May 5, 2011

Scientists of the Institute of stem cells, a new drug, based on use stem cells   Human umbilical cord blood. The drug is designed to treat severe liver disease.

A response to the invention of American scientists a new means for the treatment of hepatitis   It was a new drug "Gematsell", created with the use of hematopoietic stem cells of the blood. The drug is intended for complex treatment of liver cirrhosis and myocardial infarction . Effect of the drug is based on the ability of stem cells to stimulate the recovery of the affected tissues.

According to scientists, the drug is able to guarantee full recovery Thousands of patients in Russia suffering from hepatitis. But the question of the effectiveness of the new drug is still open. To answer this question you need to conduct clinical trials.

To date, no clinical base has not received permission to hold trials of drugs that are based on stem cells, whereas in other countries, studies of this kind, not only do not meet any obstacles in its path, but also strongly supported by the state, for example, the United States lifted a ban on the state support for embryonic stem cell research .

Currently, stem cells derived from umbilical cord blood embryo used in the treatment of a large number of diseases. As a rule, this is a very serious disease. Primarily, this is oncological diseases , Different types of anemia, some hereditary and autoimmune disease. In addition, studies have shown that stem cells from umbilical cord blood can be successfully used to treat myocardial infarction, diseases liver and nervous system.